Predictors of knowledge level and awareness towards the principles and methodology evaluation of pharmacoeconomics in Saudi Arabia by Dhafer Mahdi Alshayban

Subjects: Get full text

Oncology monoclonal antibodies expenditure trends and reimbursement projections in the emerging Balkan market by Mihajlo B Jakovljevic

Subjects: “…monoclonal antibodies, pharmaceutical expenditure, reimbursement…”
Get full text

The trend of pharmaceutical expenditure in Italy: from the report OsMed 2013 to the monitoring 2014 by Mario Eandi

Subjects: Get full text

Inventory management practices: implications on the pharmaceuticals expenditure of rabies vaccine in public health facilities, Namibia by Alemnew Dessie Shibabaw, Hilma N. Nakambale, Varsha Bangalee

Subjects: Get full text

The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy by Monica Hildegard Otto, Monica Hildegard Otto, Carla Pillarella, Claudio Jommi, Claudio Jommi

Subjects: Get full text

Corrigendum: The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy by Monica Hildegard Otto, Monica Hildegard Otto, Carla Pillarella, Claudio Jommi, Claudio Jommi

Subjects: Get full text

Outpatient antihypertensive drug utilization in Canton Sarajevo during five years period (2004-2008) and adherence to treatment guidelines assessment by Tarik Čatić, Begler Begović

Subjects: Get full text

Financial Consequences of the Act on Reimbursement of Medicines for the National Health Fund and Patients by Zofia Skrzypczak, Jadwiga Suchecka

Subjects: “…total pharmaceutical expenditure…”
Get full text

Marketing and Pricing Strategies of Blockbuster Drugs in the South Korean Market: A 15-Year Retrospective Cohort Study for Choline Alfoscerate by Jeewon Park, SeungJin Bae, Tae-Jin Lee, Tae-Jin Lee, Kyung-Bok Son

Subjects: Get full text

Public spending on orphan medicines: a review of the literature by Margit Gombocz, Sabine Vogler

Subjects: Get full text

Expenditure trends of orphan drugs in Serbia: 8-Year analysis of orphan drug market in Serbia by Pejčić Ana V., Iskrov Georgi G.

Subjects: Get full text

Estimating the fiscal effects of public pharmaceutical expenditure reduction in Greece by Kyriakos eSouliotis, Manto ePapageorgiou, Anastasia ePoliti, Nikolaos eFrangos, Yiannis eTountas

Subjects: Get full text

Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012–2013 Medical Expendi... by Joseph A. Salami, Javier Valero‐Elizondo, Oluseye Ogunmoroti, Erica S. Spatz, Jamal S. Rana, Salim S. Virani, Ron Blankstein, Adnan Younus, Alejandro Arrieta, Michael J. Blaha, Emir Veledar, Khurram Nasir

Subjects: Get full text

Optimising prescribing in primary care: an evaluation of financial and clinical parameters by Asal Albayati, David Lu, Liam Sergeant, Nandita Singh, Keith Crump, Zaheer-Ud-Din Babar

Subjects: Get full text

Factors associated with the incidence and the expenditure of self-medication among middle-aged and older adults in China: A cross-sectional study by Yuxin Liu, Zehao Zheng, Xiubo Wang, Jiabei Xia, Xingce Zhu, Fanjun Cheng, Zhiyong Liu

Subjects: Get full text

Cost-Containment of Non-Formulary Medicines Accessibility: Malaysian Experience by Nur Liyana Zainal Bahrin, Yahaya Hassan, Abu Bakar Abd Majeed, Nur Wahida Zulkifli, Azlan Ahmad

Subjects: Get full text

Which factor reduces pharmaceutical expenditure, number of entrants or price variance? Updated generic drug markets in South Korea by Kyung-Bok Son

Subjects: Get full text

The speed of adoption of new drugs and prescription volume after the amendments in reimbursement coverage: the case of non-vitamin K antagonist oral anticoagulants in South Korea by Kyung-Bok Son

Subjects: Get full text

Managing new premium-priced medicines in Europe by Govin Permanand, Hanne Bak Pedersen

Subjects: Get full text

Characteristics of High-Cost Beneficiaries of Prescription Drugs in Kazakhstan: A Cross-Sectional Study of Outpatient Data from 2022 by Nazarbayev A, Nurbakyt A, Omirbayeva B, Akhmetzhan A, Kosherbayeva L

Subjects: “…pharmaceutical expenditure…”
Get full text